Biotinylated Cynomolgus IL-18BP Protein (Primary Amine Labeling), Active
Beta LifeScience
SKU/CAT #: BLK-00658P-100UG

Biotinylated Cynomolgus IL-18BP on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Cynomolgus IL-18BP Protein (Primary Amine Labeling), Active
Beta LifeScience
SKU/CAT #: BLK-00658P-100UG
Collections: High-quality recombinant proteins, Other recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Cynomolgus IL-18BP Protein (Primary Amine Labeling) is expressed from HEK293 with His tag at the C-Terminus.It contains Thr28-Pro207. |
Purity | > 95% as determined by Tris-Bis PAGE;> 90% as determined by HPLC |
Accession | A0A2K5UDJ4 |
Target Symbol | IL-18BP |
Species | Cynomolgus |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Thr28-Pro207 |
Mol. Weight | The protein has a predicted MW of 21.14 kDa. Due to glycosylation, the protein migrates to 50-65 kDa based on Tris-Bis PAGE result. |
Form | Liquid |
Formulation | Supplied as 0.22um filtered solution in PBS (pH 7.4). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | The affinity constant of 1.67 nM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. |